INMUNE BIO, INC. (INMB)
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
Enbridge Reports Strong Second Quarter Results, Reaffirms 2026 Guidance and Grows Secured Backlog to $41B
Atlas Energy Solutions Expands AI-Enabled Digital Transformation of Oilfield Logistics with Kodiak-Powered Driverless Trucks
T. ROWE PRICE GROUP REPORTS SECOND QUARTER 2026 RESULTS
TDS and Array to release second quarter operating results and host conference call on August 7, 2026
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Collins John DeNeen
Perella Weinberg Announces Partner Promotions